Patients with mild and severe cases of COVID-19 exhibited reduced extracellular adenosine levels, which were linked to elevated concentrations of pro-inflammatory cytokines and were attributed to altered expression of CD39 and CD73 in the T cells of COVID-19 patients [155]. The gene discussed is ENTPD1; the disease is COVID-19.